Articles by Disease (Rhabdomyosarcoma)

Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers

Journal: Current Drug Targets
Volume: 12
Page: 2016-2033
Author(s): Eric K. Rowinsky, Jonathan D. Schwartz, Naseem Zojwalla, Hagop Youssoufian, Floyd Fox, Philippe Pultar, Ruslan Novosyadlyy, Jan Cosaert and Dale L. Ludwig

The Hedgehog Knows Many Tricks

Journal: Current Drug Targets
Volume: 12
Page: 2091-2095
Author(s): Glen J. Weiss, Alain C. Mita and Daniel D. Von Hoff

In Vivo Bio-imaging Using Chlorotoxin-based Conjugates

Journal: Current Pharmaceutical Design
Volume: 17
Page: 4362-4371
Author(s): Mark R. Stroud, Stacey J. Hansen and James M. Olson

The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients

Journal: Current Pharmaceutical Biotechnology
Volume: 12
Page: 1961-1973
Author(s): F. Coluccio Leskow, M. A. Krasnapolski and A. J. Urtreger

Exploitation of Apoptosis Pathways for Childhood Leukemia

Journal: Current Pediatric Reviews
Volume: 7
Page: 266-270
Author(s): Simone Fulda

Inhibition of Apoptosis in Pediatric Cancer by Survivin

Journal: Current Pediatric Reviews
Volume: 7
Page: 277-284
Author(s): Ayman Samkari and Rachel A. Altura

Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth

Journal: Current Pediatric Reviews
Volume: 7
Page: 301-309
Author(s): Farasat Zaman, Bengt Fadeel and Lars Savendahl